S M Ashrafuzzaman Selected Research

Insulin Detemir (Levemir)

12/2013

Clinical experience with BIAsp 30: Results from the Bangladesh cohort of the global A1chieve study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S M Ashrafuzzaman Research Topics

Disease

3	Type 2 Diabetes Mellitus (MODY) 05/2018 - 04/2013
2	Body Weight (Weight, Body) 04/2013 - 01/2012
1	COVID-19 01/2021
1	Endocrine System Diseases (Endocrine Diseases) 01/2021
1	Ketosis 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Hypoglycemia (Reactive Hypoglycemia) 05/2018
1	Anemia 01/2012
1	Chronic Renal Insufficiency 01/2012
1	Acute Disease 10/2011
1	Liver Diseases (Liver Disease) 10/2011
1	Heart Diseases (Heart Disease) 10/2011

Drug/Important Bio-Agent (IBA)

3	Insulin (Novolin)FDA Link 05/2018 - 04/2013
2	insulin aspart protamine drug combination 30:70 insulin aspartIBA 12/2013 - 04/2013
1	BESIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	Insulin Aspart (NovoLog)FDA Link 12/2013
1	Biphasic InsulinsIBA 12/2013
1	Insulin Detemir (Levemir)FDA Link 12/2013
1	Glucose (Dextrose)FDA LinkGeneric 04/2013
1	Erythropoietin FDA Link 01/2012
1	Nandrolone (Nortestosterone)IBA 01/2012
1	AndrogensIBA 01/2012
1	CreatinineIBA 10/2011

Therapy/Procedure

3	Therapeutics 12/2013 - 01/2012
1	Renal Dialysis (Hemodialysis) 01/2012
1	Conservative Treatment 01/2012